MODERN ANESTHESIOLOGY AND SOME OF THEIR REPRESENTATIVES. THEIR EFFECT MECHANISMS

M.Maydonov; F.Omonova

doi:10.5281/zenodo.7314349

MODERN ANESTHESIOLOGY AND SOME OF THEIR REPRESENTATIVES. THEIR EFFECT MECHANISMS

11.11.2022 International Scientific Journal "Science and Innovation". Series D. Volume 1 Issue 7

M.Maydonov , F.Omonova

Abstract. We don't know how general anesthesia works. Contrary to what was thought until relatively recently, the clinical state of anesthesia consists of several components that are mediated by the interaction of anesthetic drugs with different targets at the molecular-cellular, network, and structural-anatomical levels. Some of these drugs can have very specific molecular targets that trigger different components of "anesthesia": discrete mutations of single amino acids in certain proteins have profound effects on the ability of certain anesthetics to reach specific endpoints. does. Despite this potential specificity, inhaled anesthetics are present in the body in very high concentrations during surgical anesthesia. Due to its solubility in lipids, general anesthesia dissolves in every membrane, penetrates every organoid and can interact with a large number of cellular structures in various ways. A priori, therefore, it is not unreasonable to assume that these drugs can cause insidious changes in the body, in addition to the sharp and obvious ones that we regularly observe. Some changes may disappear shortly after withdrawal of the drug (for example, suppression of immune cell function). Others may persist and even self-reproduce after complete withdrawal of the drug, while others may be irreversible, but the significance is uncertain. This article focuses on evidence of anesthetic toxicity in the central nervous system (CNS). The CNS appears to be most sensitive to anesthetic neurotoxicity during aging, possibly through different pathways: anesthetics may induce excessive apoptosis during the peak period of synaptogenesis in neonates; In aging, CNS subtle cognitive dysfunction may persist long after drug clearance and may accelerate processes reminiscent of neurodegenerative diseases. At all ages, anesthetics affect protein synthesis that regulates gene expression in poorly understood ways. Although it seems reasonable to assume that most of our patients fully restore homeostasis after general anesthesia, it is time to recognize that the effects of these drugs are more profound and long-lasting in the brain than previously imagined[1].

Keywords: Theories of anesthetic action, Mechanisms of action of anesthetic substances through ion channels, Hypnosis, potency, sedation, hidden memory and amnesia, History of Anesthesiology.

References:

1. Kayser B, Rajaram S, Tomas S, Mor gan PG, Sedenskiy MM. C. elegansda anestezik javobni nazorat qilish. Toxicol Lett 1998;100-101:339-46. 2. Ashhurst Jr Jr. kunlaridan oldin jarrohlik 4. McLeod HL, Evans WE. Farmakologik nomika: inson genomini ochish muharrirlar. Xato qilish insonga xosdir: xavfsizroq qurish 8. Carroll NV, Miederhoff PA, Cox FM, anestetik kuch standarti. Anesteziologiya 1965;26:756-63. 3. JW Langsjo, KK Kaisti, S. Aalto, S. Hinkka, R. Aantaa, V. Oikonen, H. Sipila, T. Kurki, M. Silvanto va H. Scheinin: ketaminning subanestetik dozalarining mintaqaviy miya qoniga ta'siri odamlarda oqim, kislorod iste'moli va qon hajmi. Anesteziologiya 99(3), 614-23 (2003) 4. EI Eger, 2nd, DD Koblin, RA Xarris, JJ Kendig, A. Pohorille, MJ Halsey va JR Trudell: Gipoteza: inhalatsiyalangan anestezikalar turli joylarda turli mexanizmlar bilan harakatsizlik va amneziya hosil qiladi. Anest Analg 84(4), 915-8 (1997) 5. JF Antognini, XW Vang va E. Karstens: Orqa miyadagi izofluran ta'siri echkilarda zararli stimulyatsiyaga elektroensefalografik va talamik-retikulyar shakllanish reaktsiyalarini to'xtatadi. Anesteziologiya 92(2), 559-66 (2000) 6. Tohirova J., Shernazarov F. ATHEROSCLEROSIS: CAUSES, SYMPTOMS, DIAGNOSIS, TREATMENT AND PREVENTION //Science and innovation. – 2022. – Т. 1. – №. D5. – С. 7-12. 7. Farhod o’g’li S. F. GASTRIT—SABABLARI, ALOMATLARI, TASHXISLASH, DAVOLASH, DORILAR, ASORATLARI, OLDINI OLISH //Лучший инноватор в области науки. – 2022. – Т. 1. – №. 1. – С. 103-107. 8. Tohirova J., Shernazarov F. ATHEROSCLEROSIS: CAUSES, SYMPTOMS, DIAGNOSIS, TREATMENT AND PREVENTION //Science and innovation. – 2022. – Т. 1. – №. D5. – С. 7-12. 9. F. Shernazarov ATHEROSCLEROSIS: CAUSES, SYMPTOMS, DIAGNOSIS, TREATMENT AND PREVENTION // SAI. 2022. №D5. URL: https://cyberleninka.ru/article/n/atherosclerosis-causes-symptoms-diagnosis-treatment-and-prevention (дата обращения: 20.10.2022). 10. F. Shernazarov, J. Tohirova, D. Jalalova TYPES OF HEMORRHAGIC DISEASES, CHANGES IN NEWBOENS, THEIR EARLY DIAGNOSIS // SAI. 2022. №D5. URL: https://cyberleninka.ru/article/n/types-of-hemorrhagic-diseases-changes-in-newboens-their-early-diagnosis (дата обращения: 20.10.2022). 11. Qizi T. J. I., Farrukh S. TREATMENT OF MYOCARDIAL INFARCTION AND FIRST AID //Science and innovation. – 2022. – Т. 1. – №. D3. – С. 317-320. 12. Shernazarov F., Azimov A. INCREASED BRAIN PRESSURE-CAUSES, SYMPTOMS, COMPLICATIONS, TREATMENT //Современная медицина: новые подходы и актуальные исследования. – 2021. – С. 73-77. 13. qizi Tohirova J. I., ogʻli Ibragimov B. I., ogʻli Shernazarov F. F. CONGENITAL HEART DISEASE-CAUSES, CLASSIFICATION, DIAGNOSIS, TREATMENT, COMPLICATIONS, CONSEQUENCES //Eurasian Journal of Medical and Natural Sciences. – 2022. – Т. 2. – №. 3. – С. 84-89. 14. Mratbaevna W. N., Farrux S. The Structure of the Heart and its Physiology in Regular Athletes //Eurasian Scientific Herald. – 2022. – Т. 8. – С. 102-105. 15. Farhod o’g’li S. F. GASTRIT—SABABLARI, ALOMATLARI, TASHXISLASH, DAVOLASH, DORILAR, ASORATLARI, OLDINI OLISH //Лучший инноватор в области науки. – 2022. – Т. 1. – №. 1. – С. 103-107. 16. Фаррух Ш. и др. ПУТИ УСТРАНЕНИЯ САХАРНОГО ДИАБЕТА //Science and innovation. – 2022. – Т. 1. – №. D3. – С. 313-316. 17. ПУТИ УСТРАНЕНИЯ САХАРНОГО ДИАБЕТА. Тоҳирова Жайрона Иззатилло Қизи, Шерназаров Фаррух «Science and innovation» 2022 yil 3-sonida 313-316 bet https://doi.org/10.5281/zenodo.6803520 18. Shernazarov Farrukh. (2022). TREATMENT OF MYOCARDIAL INFARCTION AND FIRST AID. "science and Innovation" International Scientific Journal. ISSN: 2181-3337, 1(3), 317–320. https://doi.org/10.5281/zenodo.6803550 19. Shernazarov Farrux. Eurasian Scientific Herald a. P E N A C C E S S , P E E R R E V I E W E D J O U R N A L 20. HTTPS://GENIUSJOURNALS.ORG/INDEX.PHP/ESH V O L U M E 8 | M A Y 2 0 2 2 I S S N ( E ) : 2 7 9 5 - 7 3 6 5 21. The Structure of the Heart and its Physiology in Regular Athletes 102-105 https://geniusjournals.org/index.php/esh/article/view/1427 22. Shernazarov Farrukh Farkhod ogʻli. (2022). CONGENITAL HEART DISEASE - CAUSES, CLASSIFICATION, DIAGNOSIS, TREATMENT, COMPLICATIONS, CONSEQUENCES. EURASIAN JOURNAL OF MEDICAL AND NATURAL SCIENCES, 2(3), 84–89. https://doi.org/10.5281/zenodo.6408056 23. Shernazarov Farrux Farhod o'g'li. (2022). GASTRIT — SABABLARI, ALOMATLARI, TASHXISLASH, DAVOLASH, DORILAR, ASORATLARI, OLDINI OLISH. The Best Innovator in Science, 1(1), 103–107. https://doi.org/10.5281/zenodo.6023027 24. ПУТИ УСТРАНЕНИЯ САХАРНОГО ДИАБЕТА. Тоҳирова Жайрона Иззатилло Қизи, Шерназаров Фаррух «Science and innovation» https://cyberleninka.ru/article/n/puti-ustraneniya-saharnogo-diabeta 25. Shernazarov Farrukh. (2022). TREATMENT OF MYOCARDIAL INFARCTION AND FIRST AID. "science and Innovation" International Scientific Journal. ISSN: 2181-3337, 1(3), 317–320. 26. https://cyberleninka.ru/article/n/treatment-of-myocardial-infarction-and-first-aid 27. F. Shernazarov, J. Tohirova, D. Jalalova TYPES OF HEMORRHAGIC DISEASES, CHANGES IN NEWBOENS, THEIR EARLY DIAGNOSIS // SAI. 2022. №D5. URL: https://cyberleninka.ru/article/n/types-of-hemorrhagic-diseases-changes-in-newboens-their-early-diagnosis (дата обращения: 29.10.2022). 28. qizi Tohirova J. I., ogʻli Ibragimov B. I., ogʻli Shernazarov F. F. CONGENITAL HEART DISEASE-CAUSES, CLASSIFICATION, DIAGNOSIS, TREATMENT, COMPLICATIONS, CONSEQUENCES //Eurasian Journal of Medical and Natural Sciences. – 2022. – Т. 2. – №. 3. – С. 84-89. 29. qizi Tohirova J. I., ogʻli Ibragimov B. I., ogʻli Shernazarov F. F. CONGENITAL HEART DISEASE-CAUSES, CLASSIFICATION, DIAGNOSIS, TREATMENT, COMPLICATIONS, CONSEQUENCES //Eurasian Journal of Medical and Natural Sciences. – 2022. – Т. 2. – №. 3. – С. 84-89. 30. SG Brickley, SG Cull-Candy va M. Farrant: GABAA retseptorlarining doimiy faollashuvidan kelib chiqadigan kalamush serebellar granula hujayralarida sinaptik inhibisyonning tonik shaklini ishlab chiqish. J Physiol 497 (Pt 3), 753-9 (1996) 31. H. Hentschke, C. Schwarz va B. Antkowiak: Neokorteks uchuvchi anestetiklarning sedativ kontsentratsiyasining asosiy maqsadi hisoblanadi: otish tezligining kuchli tushkunligi va GABAA retseptorlari vositachiligida inhibisyonning kuchayishi. Eur J Neurosci 21(1), 93-102 (2005) 32. K. Solt, EW Kelly, JF Cotten va DE Raines: uchuvchi aromatik anesteziklar tomonidan inson alpha4beta2 neyronal nikotinik atsetilxolin retseptorlarini inhibe qilish preparatning hidrofobikligiga bog'liq. Anestezik analg 110 (2), 455-60 (2010) 33. A. Zeller, M. Arras, R. Jurd va U. Rudolf: beta3 o'z ichiga olgan GABAA retseptorlarining uchuvchi va tomir ichiga yuboriladigan umumiy anestezik harakatlariga qo'shgan hissasini xaritalash. BMC Pharmacol 7, 2 (2007) 34. Nagase, Y.; Kaibara, M.; Uezono, Y.; Izumi, F. K.; Taniyama, K. Jpn. J. Farmakol., 1999, 79, 319. 35. Orser, BA; Vang, LY; Pennefather, PS; MakDonald, JFJ. Neurosci., 1994, 14, 7747.